First Trust NYSE Arca Biotechnology UCITS ETF (FBT.L) Price

First Trust NYSE Arca Biotechnology UCITS ETF is offered by First Trust, a leading player in the field of passive investments.

The ISIN of First Trust NYSE Arca Biotechnology UCITS ETF is IE00BL0L0H60.

The total expense ratio of First Trust NYSE Arca Biotechnology UCITS ETF is 0.60%, which means that investors pay 60.00 USD per 10,000 USD in investment capital annually.

The ETF is listed in USD.

European investors may incur additional costs for currency exchange and transaction fees.

Yes, First Trust NYSE Arca Biotechnology UCITS ETF complies with the EU UCITS investor protection directives.

The P/E ratio of First Trust NYSE Arca Biotechnology UCITS ETF is 22.71.

First Trust NYSE Arca Biotechnology UCITS ETF tracks the performance of the NYSE Arca Biotechnology Index.

First Trust NYSE Arca Biotechnology UCITS ETF is domiciled in IE.

The fund was launched on 5/27/2020.

The First Trust NYSE Arca Biotechnology UCITS ETF mainly invests in Healthcare companies.

The NAV of First Trust NYSE Arca Biotechnology UCITS ETF amounts to 24.75 M USD.

The price-to-book ratio is 3.45.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.